Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
BHRB vs MNSB vs NBTB vs CARE vs FIS vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Information Technology Services
Banks - Diversified
BHRB vs MNSB vs NBTB vs CARE vs FIS vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||||
|---|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Information Technology Services | Banks - Diversified |
| Market Cap | $1.01B | $184M | $2.52B | $662M | $20.26B | $896.00B |
| Revenue (TTM) | $487M | $135M | $902M | $252M | $11.66B | $280.33B |
| Net Income (TTM) | $117M | $16M | $169M | $31M | $2.67B | $57.05B |
| Gross Margin | 69.1% | 54.3% | 73.6% | 61.2% | 37.6% | 60.0% |
| Operating Margin | 29.7% | 14.1% | 24.3% | 15.9% | 17.9% | 25.9% |
| Forward P/E | 8.3x | 11.0x | 11.5x | 5.5x | 6.2x | 14.4x |
| Total Debt | $537M | $70M | $327M | $179M | $4.01B | $942.38B |
| Cash & Equiv. | $53M | $26M | $185M | $105M | $599M | $343.34B |
BHRB vs MNSB vs NBTB vs CARE vs FIS vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Burke & Herbert Fin… (BHRB) | 100 | 155.3 | +55.3% |
| MainStreet Bancshar… (MNSB) | 100 | 188.9 | +88.9% |
| NBT Bancorp Inc. (NBTB) | 100 | 156.6 | +56.6% |
| Carter Bankshares, … (CARE) | 100 | 370.2 | +270.2% |
| Fidelity National I… (FIS) | 100 | 29.2 | -70.8% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BHRB vs MNSB vs NBTB vs CARE vs FIS vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BHRB is the #2 pick in this set and the best alternative if growth exposure and bank quality is your priority.
- Rev growth 23.7%, EPS growth 231.2%
- NIM 3.7% vs JPM's 2.2%
- 23.7% NII/revenue growth vs MNSB's -1.4%
- 24.1% margin vs MNSB's 11.5%
MNSB lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 6 stocks, NBTB doesn't own a clear edge in any measured category.
CARE ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.58, Low D/E 42.5%, current ratio 0.75x
- Beta 0.58 vs JPM's 0.94, lower leverage
- +79.6% vs FIS's -49.4%
FIS carries the broadest edge in this set and is the clearest fit for income & stability and valuation efficiency.
- Dividend streak 1 yrs, beta 0.61, yield 4.2%
- PEG 0.26 vs NBTB's 1.64
- Beta 0.61, yield 4.2%, current ratio 0.59x
- Lower P/E (6.2x vs 14.4x), PEG 0.26 vs 0.81
JPM is the clearest fit if your priority is long-term compounding.
- 465.8% 10Y total return vs CARE's 141.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.7% NII/revenue growth vs MNSB's -1.4% | |
| Value | Lower P/E (6.2x vs 14.4x), PEG 0.26 vs 0.81 | |
| Quality / Margins | 24.1% margin vs MNSB's 11.5% | |
| Stability / Safety | Beta 0.58 vs JPM's 0.94, lower leverage | |
| Dividends | 4.2% yield, 1-year raise streak, vs JPM's 1.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +79.6% vs FIS's -49.4% | |
| Efficiency (ROA) | 7.5% ROA vs CARE's 0.7%, ROIC 6.0% vs 5.7% |
BHRB vs MNSB vs NBTB vs CARE vs FIS vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BHRB vs MNSB vs NBTB vs CARE vs FIS vs JPM — Financial Metrics
Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BHRB leads in 1 of 6 categories
FIS leads 1 • JPM leads 1 • MNSB leads 0 • NBTB leads 0 • CARE leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BHRB leads this category, winning 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 2069.4x MNSB's $135M. BHRB is the more profitable business, keeping 24.1% of every revenue dollar as net income compared to MNSB's 11.5%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $487M | $135M | $902M | $252M | $11.7B | $280.3B |
| EBITDAEarnings before interest/tax | $162M | $23M | $241M | $46M | $4.1B | $81.4B |
| Net IncomeAfter-tax profit | $117M | $16M | $169M | $31M | $2.7B | $57.0B |
| Free Cash FlowCash after capex | $96M | $11M | $225M | $30M | $2.8B | $100.9B |
| Gross MarginGross profit ÷ Revenue | +69.1% | +54.3% | +73.6% | +61.2% | +37.6% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +29.7% | +14.1% | +24.3% | +15.9% | +17.9% | +25.9% |
| Net MarginNet income ÷ Revenue | +24.1% | +11.5% | +18.8% | +12.5% | +22.9% | +20.4% |
| FCF MarginFCF ÷ Revenue | +19.7% | +7.9% | +24.9% | +11.9% | +23.9% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | +30.1% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +53.8% | +120.9% | +39.5% | +8.3% | +30.6% | +16.0% |
Valuation Metrics
Evenly matched — BHRB and MNSB and FIS each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 8.7x trailing earnings, BHRB trades at a 83% valuation discount to FIS's 52.3x P/E. Adjusting for growth (PEG ratio), BHRB offers better value at 0.47x vs FIS's 2.14x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Market CapShares × price | $1.0B | $184M | $2.5B | $662M | $20.3B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $227M | $2.7B | $735M | $23.7B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 8.66x | 14.16x | 14.47x | 21.34x | 52.27x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.29x | 11.03x | 11.54x | 5.47x | 6.24x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | 0.47x | — | 2.06x | — | 2.14x | 0.90x |
| EV / EBITDAEnterprise value multiple | 10.29x | 11.90x | 11.03x | 18.38x | 6.50x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 2.05x | 1.35x | 2.90x | 2.60x | 1.90x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.18x | 0.87x | 1.29x | 1.60x | 1.46x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 10.48x | 17.26x | 11.49x | 20.81x | 7.21x | 8.88x |
Profitability & Efficiency
FIS leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
FIS delivers a 18.4% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $7 for MNSB. NBTB carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | ||||||
|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +14.6% | +7.3% | +9.5% | +7.6% | +18.4% | +15.9% |
| ROA (TTM)Return on assets | +1.5% | +0.7% | +1.1% | +0.7% | +7.5% | +1.3% |
| ROICReturn on invested capital | +8.4% | +5.0% | +7.9% | +5.7% | +6.0% | +4.5% |
| ROCEReturn on capital employed | +3.5% | +6.0% | +2.4% | +1.5% | +6.6% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 7 | 8 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.63x | 0.32x | 0.17x | 0.43x | 0.29x | 2.60x |
| Net DebtTotal debt minus cash | $484M | $43M | $142M | $73M | $3.4B | $599.0B |
| Cash & Equiv.Liquid assets | $53M | $26M | $185M | $105M | $599M | $343.3B |
| Total DebtShort + long-term debt | $537M | $70M | $327M | $179M | $4.0B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.97x | 0.31x | 1.05x | 0.39x | 21.16x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $3,267 for FIS. Over the past 12 months, CARE leads with a +79.6% total return vs FIS's -49.4%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs FIS's -6.8% — a key indicator of consistent wealth creation.
| Metric | ||||||
|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +10.4% | +26.5% | +17.6% | +54.3% | -38.9% | -0.5% |
| 1-Year ReturnPast 12 months | +17.9% | +37.2% | +18.3% | +79.6% | -49.4% | +21.8% |
| 3-Year ReturnCumulative with dividends | -8.8% | +13.1% | +48.5% | +93.9% | -18.9% | +138.2% |
| 5-Year ReturnCumulative with dividends | +51.7% | +18.1% | +44.4% | +108.0% | -67.3% | +118.2% |
| 10-Year ReturnCumulative with dividends | +80.9% | +135.4% | +108.5% | +141.7% | -25.6% | +465.8% |
| CAGR (3Y)Annualised 3-year return | -3.0% | +4.2% | +14.1% | +24.7% | -6.8% | +33.6% |
Risk & Volatility
Evenly matched — NBTB and CARE each lead in 1 of 2 comparable metrics.
Risk & Volatility
CARE is the less volatile stock with a 0.58 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NBTB currently trades 99.8% from its 52-week high vs FIS's 47.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.81x | 0.60x | 0.76x | 0.58x | 0.61x | 0.94x |
| 52-Week HighHighest price in past year | $70.90 | $25.17 | $48.27 | $29.99 | $82.74 | $337.25 |
| 52-Week LowLowest price in past year | $55.40 | $17.86 | $39.20 | $16.14 | $37.91 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +94.6% | +99.0% | +99.8% | +99.6% | +47.4% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 64.0 | 65.3 | 63.1 | 72.8 | 30.8 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 146K | 45K | 266K | 316K | 5.6M | 7.0M |
Analyst Outlook
Evenly matched — FIS and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BHRB as "Buy", MNSB as "Hold", NBTB as "Hold", CARE as "Hold", FIS as "Buy", JPM as "Buy". Consensus price targets imply 60.4% upside for FIS (target: $63) vs -4.6% for CARE (target: $29). For income investors, FIS offers the higher dividend yield at 4.16% vs MNSB's 1.60%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $74.00 | — | $46.00 | $28.50 | $62.88 | $339.75 |
| # AnalystsCovering analysts | 3 | 1 | 10 | 5 | 37 | 61 |
| Dividend YieldAnnual dividend ÷ price | +3.4% | +1.6% | +3.0% | — | +4.2% | +1.9% |
| Dividend StreakConsecutive years of raises | 2 | 0 | 13 | 0 | 1 | 15 |
| Dividend / ShareAnnual DPS | $2.26 | $0.40 | $1.43 | — | $1.63 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.4% | +0.4% | +3.0% | +7.0% | +3.9% |
BHRB leads in 1 of 6 categories (Income & Cash Flow). FIS leads in 1 (Profitability & Efficiency). 3 tied.
BHRB vs MNSB vs NBTB vs CARE vs FIS vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BHRB or MNSB or NBTB or CARE or FIS or JPM a better buy right now?
For growth investors, Burke & Herbert Financial Services Corp.
(BHRB) is the stronger pick with 23. 7% revenue growth year-over-year, versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). Burke & Herbert Financial Services Corp. (BHRB) offers the better valuation at 8. 7x trailing P/E (8. 3x forward), making it the more compelling value choice. Analysts rate Burke & Herbert Financial Services Corp. (BHRB) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BHRB or MNSB or NBTB or CARE or FIS or JPM?
On trailing P/E, Burke & Herbert Financial Services Corp.
(BHRB) is the cheapest at 8. 7x versus Fidelity National Information Services, Inc. at 52. 3x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Fidelity National Information Services, Inc. wins at 0. 26x versus NBT Bancorp Inc. 's 1. 64x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BHRB or MNSB or NBTB or CARE or FIS or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to -67. 3% for Fidelity National Information Services, Inc. (FIS). Over 10 years, the gap is even starker: JPM returned +465. 8% versus FIS's -25. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BHRB or MNSB or NBTB or CARE or FIS or JPM?
By beta (market sensitivity over 5 years), Carter Bankshares, Inc.
(CARE) is the lower-risk stock at 0. 58β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 64% more volatile than CARE relative to the S&P 500. On balance sheet safety, NBT Bancorp Inc. (NBTB) carries a lower debt/equity ratio of 17% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — BHRB or MNSB or NBTB or CARE or FIS or JPM?
By revenue growth (latest reported year), Burke & Herbert Financial Services Corp.
(BHRB) is pulling ahead at 23. 7% versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). On earnings-per-share growth, the picture is similar: Burke & Herbert Financial Services Corp. grew EPS 231. 2% year-over-year, compared to -47. 2% for Fidelity National Information Services, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BHRB or MNSB or NBTB or CARE or FIS or JPM?
Burke & Herbert Financial Services Corp.
(BHRB) is the more profitable company, earning 23. 9% net margin versus 3. 6% for Fidelity National Information Services, Inc. — meaning it keeps 23. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BHRB leads at 29. 5% versus 14. 0% for MNSB. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BHRB or MNSB or NBTB or CARE or FIS or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Fidelity National Information Services, Inc. (FIS) is the more undervalued stock at a PEG of 0. 26x versus NBT Bancorp Inc. 's 1. 64x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 5. 5x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 8. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FIS: 60. 4% to $62. 88.
08Which pays a better dividend — BHRB or MNSB or NBTB or CARE or FIS or JPM?
In this comparison, FIS (4.
2% yield), BHRB (3. 4% yield), NBTB (3. 0% yield), JPM (1. 9% yield), MNSB (1. 6% yield) pay a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.
09Is BHRB or MNSB or NBTB or CARE or FIS or JPM better for a retirement portfolio?
For long-horizon retirement investors, MainStreet Bancshares, Inc.
(MNSB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 60), 1. 6% yield, +135. 4% 10Y return). Both have compounded well over 10 years (MNSB: +135. 4%, CARE: +141. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BHRB and MNSB and NBTB and CARE and FIS and JPM?
These companies operate in different sectors (BHRB (Financial Services) and MNSB (Financial Services) and NBTB (Financial Services) and CARE (Financial Services) and FIS (Technology) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BHRB is a small-cap high-growth stock; MNSB is a small-cap deep-value stock; NBTB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock; FIS is a mid-cap income-oriented stock; JPM is a large-cap deep-value stock. BHRB, MNSB, NBTB, FIS, JPM pay a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.